The company said its officers plan to reaffirm full-year 2025 shareholders' earnings guidance of $28.30 to $29.00 per diluted share, including approximately $5.85 per diluted share of net unfavorable items.

8-KRegulation FD DisclosureFiled May 28, 2025Period of report May 28, 2025Summary published (UTC) Oct 14, 2026

Key points

AI summary

The company said its officers plan to reaffirm full-year 2025 shareholders' earnings guidance of $28.30 to $29.00 per diluted share, including approximately $5.85 per diluted share of net unfavorable items.
The company said it continues to expect adjusted shareholders' earnings of $34.15 to $34.85 per diluted share excluding these items, and that this does not include any adjustment items beyond those reported in its Q1 2025 earnings.
The company said its officers also expect to reaffirm full-year 2025 benefit expense ratio guidance of 89.1%, plus or minus 50 basis points.
The company said it expects 60% of adjusted shareholders' earnings per diluted share to be realized in the first half of 2025. It explained that this outlook reflects management's current view of key assumptions, including cost trends and medical claims payable estimates.

Summary

AI-written

Analysis scope · Filing bodyWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.

Reaffirms Full-Year 2025 Adjusted Shareholders' Earnings Guidance

The company said its officers plan to reaffirm full-year 2025 shareholders' earnings guidance of $28.30 to $29.00 per diluted share, including approximately $5.85 per diluted share of net unfavorable items.

Source · Based on the filing body and exhibits

Adjusted Shareholders' Earnings Guidance of $34.15 to $34.85 per Diluted Share

The company said it continues to expect adjusted shareholders' earnings of $34.15 to $34.85 per diluted share excluding these items, and that this does not include any adjustment items beyond those reported in its Q1 2025 earnings.

Source · Based on the filing body and exhibits

Full-Year 2025 Benefit Expense Ratio Outlook

The company said its officers also expect to reaffirm full-year 2025 benefit expense ratio guidance of 89.1%, plus or minus 50 basis points.

Source · Based on the filing body and exhibits

Share of Adjusted Diluted EPS Realized in First Half and Outlook Assumptions

The company said it expects 60% of adjusted shareholders' earnings per diluted share to be realized in the first half of 2025. It explained that this outlook reflects management's current view of key assumptions, including cost trends and medical claims payable estimates.

Source · Based on the filing body and exhibits

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.

View the original filing on SEC EDGAR ↗

Unauthorized scraping, data storage and database creation prohibited

Without prior written consent, you must not crawl or scrape data compiled and organized by Chickstock or its analysis and summaries, or collect them repeatedly or in bulk for storage, ingestion or database creation. Repurposing, redistribution, sale and use to build other services are also prohibited.

Unauthorized use may result in access restrictions, demands to stop infringement and delete copies, and claims for damages. Violations of applicable law may also give rise to criminal liability.

Uses permitted by law, the Terms of Service or a separate agreement remain subject to their respective scope. Rights in individual source materials, including original filings, remain with their respective rights holders.